Article
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Sanaregen Vision Therapeutics invites prospective investors to reserve stock shares
3 Things You Should Know About Interventional Glaucoma Comanagement
PYC to finalize registrational study for RP11 after positive FDA feedback
Patient-Centered Treatment Strategies in the Management of nAMD and DME
Retinal Degeneration Fund providing funding to Opus Genetics to support OPGx-MERTK program
Wilmer Eye Institute marks 100 years: honoring the past, shaping the future